ARTICLE | Financial News
Akebia raises $58M in follow-on
July 7, 2017 8:22 PM UTC
On June 28, kidney disease company Akebia Therapeutics Inc. (NASDAQ:AKBA) raised $58 million through the sale of 4 million shares at $14.50 in a follow-on underwritten by Morgan Stanley, JMP Securiti...
BCIQ Company Profiles